• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性乙型肝炎的自然史及预后因素

Natural history and prognostic factors for chronic hepatitis type B.

作者信息

Fattovich G, Brollo L, Giustina G, Noventa F, Pontisso P, Alberti A, Realdi G, Ruol A

机构信息

Istituto di Medicina Clinica, Clinica Medica 2, Università di Padova, Italy.

出版信息

Gut. 1991 Mar;32(3):294-8. doi: 10.1136/gut.32.3.294.

DOI:10.1136/gut.32.3.294
PMID:2013423
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1378837/
Abstract

One hundred and five hepatitis B surface antigen (HBsAg) positive patients presenting with chronic persistent hepatitis (n = 46) or chronic active hepatitis without cirrhosis (n = 59) were followed longitudinally for one to 16 years (mean 5.5 years) and underwent follow up biopsy. During a mean histological follow up of 3.7 years, active cirrhosis developed in 21 (20%) patients one to 13 years after entry to the study with a calculated annual incidence of 5.9%. The probability of evolution to cirrhosis was significantly higher in patients with chronic active hepatitis and bridging hepatic necrosis than in those with moderate chronic active hepatitis or chronic persistent hepatitis (p less than 0.0001). Cox multiple regression analysis showed that the following three variables independently implied poor prognosis: older age, presence of bridging hepatic necrosis, and persistence of hepatitis B virus DNA in serum (p less than 0.0001). These findings indicate that patients with severe chronic active hepatitis and persistent hepatitis B virus replication are at very high risk of rapid progression to cirrhosis.

摘要

105例乙肝表面抗原(HBsAg)阳性的慢性持续性肝炎患者(n = 46)或无肝硬化的慢性活动性肝炎患者(n = 59),进行了1至16年(平均5.5年)的纵向随访,并接受了随访活检。在平均3.7年的组织学随访期间,21例(20%)患者在进入研究1至13年后发展为活动性肝硬化,计算出的年发病率为5.9%。慢性活动性肝炎合并桥接性肝坏死患者发展为肝硬化的概率显著高于中度慢性活动性肝炎或慢性持续性肝炎患者(p < 0.0001)。Cox多因素回归分析显示,以下三个变量独立提示预后不良:年龄较大、存在桥接性肝坏死以及血清中乙肝病毒DNA持续存在(p < 0.0001)。这些发现表明,重度慢性活动性肝炎且乙肝病毒持续复制的患者快速进展为肝硬化的风险非常高。

相似文献

1
Natural history and prognostic factors for chronic hepatitis type B.慢性乙型肝炎的自然史及预后因素
Gut. 1991 Mar;32(3):294-8. doi: 10.1136/gut.32.3.294.
2
Incidence, determinants and significance of delayed clearance of serum HBsAg in chronic hepatitis B virus infection: a prospective study.慢性乙型肝炎病毒感染中血清HBsAg清除延迟的发生率、决定因素及意义:一项前瞻性研究
Hepatology. 1991 Apr;13(4):627-31.
3
The development of cirrhosis in patients with chronic type B hepatitis: a prospective study.慢性乙型肝炎患者肝硬化的发展:一项前瞻性研究。
Hepatology. 1988 May-Jun;8(3):493-6. doi: 10.1002/hep.1840080310.
4
[Long-term clinical observations of chronic active hepatitis HBsAg (+)].慢性活动性乙型肝炎表面抗原阳性的长期临床观察
Pol Arch Med Wewn. 1992 Oct;88(4):250-5.
5
Development of cirrhosis after chronic type B hepatitis: a clinicopathologic and follow-up study of 46 HBeAg-positive asymptomatic patients.慢性乙型肝炎后肝硬化的发生:46例HBeAg阳性无症状患者的临床病理及随访研究
Am J Gastroenterol. 1991 May;86(5):560-4.
6
Acute exacerbations in chronic hepatitis C: a clinicopathological and prognostic study.慢性丙型肝炎的急性加重:一项临床病理与预后研究。
J Hepatol. 1996 May;24(5):525-31. doi: 10.1016/s0168-8278(96)80136-x.
7
Factors predictive of liver cirrhosis in patients with chronic hepatitis B: a multivariate analysis in a longitudinal study.慢性乙型肝炎患者肝硬化的预测因素:一项纵向研究中的多变量分析
Eur J Gastroenterol Hepatol. 2000 Jun;12(6):687-93. doi: 10.1097/00042737-200012060-00019.
8
State of hepatitis B virus DNA in hepatocytes of patients with noncarcinomatous liver disease. Its special relationship with necroinflammatory activity and the stage of disease.非癌性肝病患者肝细胞中乙型肝炎病毒DNA的状态。其与坏死性炎症活动及疾病阶段的特殊关系。
Arch Pathol Lab Med. 1989 Jan;113(1):20-5.
9
The prognostic significance of bridging hepatic necrosis in chronic type B hepatitis: a histopathologic study.慢性乙型肝炎中桥接性肝坏死的预后意义:一项组织病理学研究。
Liver. 1988 Feb;8(1):10-6. doi: 10.1111/j.1600-0676.1988.tb00960.x.
10
Survival in chronic hepatitis B. An analysis of 379 patients.慢性乙型肝炎的生存情况。对379例患者的分析。
Ann Intern Med. 1984 Nov;101(5):613-6. doi: 10.7326/0003-4819-101-5-613.

引用本文的文献

1
Long-Term Outcome of Chronic Hepatitis B-Histological Score and Viral Genotype Are Important Predictors of Hepatocellular Carcinoma.慢性乙型肝炎的长期预后——组织学评分和病毒基因型是肝细胞癌的重要预测指标。
J Viral Hepat. 2025 Mar;32(3):e70008. doi: 10.1111/jvh.70008.
2
Liver histological changes in untreated chronic hepatitis B patients in indeterminate phase.未治疗的不确定期慢性乙型肝炎患者的肝脏组织学变化。
World J Hepatol. 2024 Jun 27;16(6):920-931. doi: 10.4254/wjh.v16.i6.920.
3
Unraveling the Complexity of Atypical Serological Profiles in Chronic Hepatitis B: Insights Into Disease Dynamics and Clinical Implications.解析慢性乙型肝炎非典型血清学特征的复杂性:对疾病动态和临床意义的见解
Cureus. 2023 Sep 8;15(9):e44899. doi: 10.7759/cureus.44899. eCollection 2023 Sep.
4
Prevalence of hepatitis B virus and immunity status among healthcare workers in Beira City, Mozambique.莫桑比克贝拉市医护人员乙型肝炎病毒感染及免疫状况。
PLoS One. 2022 Oct 14;17(10):e0276283. doi: 10.1371/journal.pone.0276283. eCollection 2022.
5
Ongoing Clinical Trials in Aging-Related Tissue Fibrosis and New Findings Related to AhR Pathways.衰老相关组织纤维化的正在进行的临床试验及与芳烃受体(AhR)通路相关的新发现。
Aging Dis. 2022 Jun 1;13(3):732-752. doi: 10.14336/AD.2021.1105. eCollection 2022 Jun.
6
Insights Into the Coinfections of Human Immunodeficiency Virus-Hepatitis B Virus, Human Immunodeficiency Virus-Hepatitis C Virus, and Hepatitis B Virus-Hepatitis C Virus: Prevalence, Risk Factors, Pathogenesis, Diagnosis, and Treatment.人类免疫缺陷病毒-乙型肝炎病毒、人类免疫缺陷病毒-丙型肝炎病毒和乙型肝炎病毒-丙型肝炎病毒合并感染的研究进展:患病率、危险因素、发病机制、诊断和治疗
Front Microbiol. 2022 Feb 3;12:780887. doi: 10.3389/fmicb.2021.780887. eCollection 2021.
7
Risk and Prevention of Hepatitis B Virus Reactivation during Immunosuppression for Non-Oncological Diseases.非肿瘤性疾病免疫抑制期间乙型肝炎病毒再激活的风险与预防
J Clin Med. 2021 Nov 8;10(21):5201. doi: 10.3390/jcm10215201.
8
HBV/HIV Coinfection: Impact on the Development and Clinical Treatment of Liver Diseases.乙肝病毒/艾滋病毒合并感染:对肝脏疾病发展及临床治疗的影响
Front Med (Lausanne). 2021 Oct 4;8:713981. doi: 10.3389/fmed.2021.713981. eCollection 2021.
9
Diagnosis and Therapeutic Management of Liver Fibrosis by MicroRNA.miRNA 对肝纤维化的诊断与治疗管理
Int J Mol Sci. 2021 Jul 29;22(15):8139. doi: 10.3390/ijms22158139.
10
Relationship Between Diabetes Mellitus and Cirrhosis Risk in Chronic Hepatitis B Patients in Wuhan, China.中国武汉慢性乙型肝炎患者中糖尿病与肝硬化风险的关系。
Med Sci Monit. 2019 Oct 29;25:8112-8119. doi: 10.12659/MSM.917000.

本文引用的文献

1
Seroconversion from hepatitis B e antigen to anti-HBe in chronic hepatitis B virus infection.慢性乙型肝炎病毒感染中乙肝e抗原血清学转换为抗-HBe。
Gastroenterology. 1980 Aug;79(2):195-9.
2
Chronic persistent hepatitis: serological classification and meaning of the hepatitis B e system.慢性持续性肝炎:乙型肝炎e系统的血清学分类及意义
Hepatology. 1982 Mar-Apr;2(2):243-6. doi: 10.1002/hep.1840020209.
3
Specificity of T lymphocyte cytotoxicity to autologous hepatocytes in chronic hepatitis B virus infection: evidence that T cells are directed against HBV core antigen expressed on hepatocytes.慢性乙型肝炎病毒感染中T淋巴细胞对自体肝细胞细胞毒性的特异性:T细胞针对肝细胞上表达的乙肝病毒核心抗原的证据
J Immunol. 1982 Dec;129(6):2773-8.
4
Analysis of liver disease, nuclear HBcAg, viral replication, and hepatitis B virus DNA in liver and serum of HBeAg Vs. anti-HBe positive carriers of hepatitis B virus.HBeAg阳性与抗-HBe阳性乙肝病毒携带者肝脏和血清中肝病、核心乙肝表面抗原、病毒复制及乙肝病毒DNA的分析
Hepatology. 1983 Sep-Oct;3(5):656-62. doi: 10.1002/hep.1840030505.
5
Age-specific prevalence and significance of hepatitis B e antigen and antibody in chronic hepatitis B virus infection in Taiwan: a comparison among asymptomatic carriers, chronic hepatitis, liver cirrhosis, and hepatocellular carcinoma.台湾慢性乙型肝炎病毒感染中乙肝e抗原和抗体的年龄特异性患病率及意义:无症状携带者、慢性肝炎、肝硬化和肝细胞癌之间的比较
J Med Virol. 1984;13(4):385-91. doi: 10.1002/jmv.1890130410.
6
The natural course of hepatitis B surface antigen-positive chronic active hepatitis in Taiwan.台湾地区乙肝表面抗原阳性慢性活动性肝炎的自然病程
J Infect Dis. 1982 Aug;146(2):205-10. doi: 10.1093/infdis/146.2.205.
7
Natural history of liver disease in chronic hepatitis B surface antigen carriers. Survey of 100 patients from Great Britain.慢性乙型肝炎表面抗原携带者的肝脏疾病自然史。对来自英国的100名患者的调查。
Lancet. 1981 Nov 21;2(8256):1156-9. doi: 10.1016/s0140-6736(81)90600-0.
8
Natural history of hepatitis-associated antigen-positive chronic liver disease.肝炎相关抗原阳性慢性肝病的自然史
Lancet. 1972 Dec 30;2(7792):1388-93. doi: 10.1016/s0140-6736(72)92963-7.
9
Clinical, virologic and histologic outcome following seroconversion from HBeAg to anti-HBe in chronic hepatitis type B.慢性乙型肝炎患者HBeAg血清学转换为抗-HBe后的临床、病毒学及组织学转归
Hepatology. 1986 Mar-Apr;6(2):167-72. doi: 10.1002/hep.1840060203.
10
Compensated cirrhosis: natural history and prognostic factors.代偿期肝硬化:自然史及预后因素
Hepatology. 1987 Jan-Feb;7(1):122-8. doi: 10.1002/hep.1840070124.